This month, the European Parliament’s Committee on the Environment, Public Health and Food Safety released a draft report on fraud in the EU food chain. Although the incidence of food fraud is increasing, the EU has no framework in place to address it and methods for dealing with it vary widely among member states. The […]
For the one thousand public companies that spend the most on R&D, R&D spending increased 5.8% in fiscal 2013 (the fiscal year ending prior to June 30) to $638 billion, down from 9.6% last year. The total share of revenues spent on R&D increased from 3.43% to 3.60%. Computing and electronics, health care, automotive, industrials, […]
Immunotherapy drugs, known as immune checkpoint inhibitors, could revolutionize cancer treatment and become a major drug market. Bristol-Myers Squibb, Merck & Co. and Roche are among the firms developing such drugs, which use the immune system to target tumor cells. Yervoy, made by Bristol-Myers, the market leader, is approved for treating melanoma, but shows potential […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
